Accessibility Menu
Organigram Global logo

Organigram Global(TSX) OGI

Current PriceCA$1.29
Market CapCA$174.68MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2014)-84%
5 Year-90%
1 Year-39%
1 Month-7%
Organigram Global last closing stock price
MetricPriceDate
Last closeCAD 1.282026-07-22
Organigram Global stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+4.07%CAD 1.232026-07-15
1 month-7.25%CAD 1.382026-06-22
3 month-34.36%CAD 1.952026-04-23
Year to date-44.59%CAD 2.312025-12-31
1 year-39.34%CAD 2.112025-07-22
3 year-28.49%CAD 1.792023-07-21
5 year-89.61%CAD 12.322021-07-23
Since inception-84%CAD 8.002014-08-26

Organigram Global Financials at a Glance

Market Cap

CA$174.68MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

CA$274.19M

Net Income (TTM)

-CA$25.21M

EPS (TTM)

-CA$0.19

P/E Ratio

-6.77

Dividend

CA$0.00

Beta (Volatility)

1.84 (High)

Price

CA$1.29

Volume

1,054

Open

CA$1.29

Previous Close

CA$1.28

Daily Range

CA$1.29 - CA$1.29

52-Week Range

CA$1.20 - CA$3.09

Estimated Earnings Date

Aug 12, 2026

OGI News

A chart line and arrow moving down.

Why Organigram Holdings Stock Is Plummeting Today

Keith NoonanApr 12, 2023
GettyImages-668519916

OrganiGram Releases Cannabis 2.0 Products To Medical Users

Bradley FreemanMay 28, 2020

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Organigram Global

OrganiGram Holdings Inc. is a Canadian company that cultivates, manufactures, and distributes cannabis and cannabis-derived products. The company operates in both medical and recreational markets, offering a diverse range of products under various brands.

Products and Services
  • Medical cannabis including dried flowers, oils, and vaporizers
  • Recreational cannabis products, edibles, and concentrates
  • Wholesale supply of cannabis plant cuttings and dried flowers
Growth Outlook
  • Recent quarterly revenue reached CAD 59.79 million, indicating strong market demand
  • Expansion into new product lines is expected to drive future growth
  • Strategic partnerships with retailers enhance distribution capabilities
Financial Highlights
  • Trailing twelve months revenue of CAD 246.93 million reflects a solid market presence
  • Current ratio of 2.82 indicates strong liquidity and financial health
  • Net income for the latest quarter was CAD -0.92 million, showing potential for recovery
AI Generated • Jun 23, 2026

Industry

Pharmaceuticals

Sector

Health Care

Employees

1,139

CEO

James Hideo Yamanaka, MBA

Website

www.organigram.ca

Headquarters

Toronto, ON M5H 1J8, CA

OGI Financials

Key Financial Metrics (TTM)

Gross Margin

-3.07%

Operating Margin

-38.62%

Net Income Margin

-9.19%

Return on Equity

-6.83%

Return on Capital

-24.68%

Return on Assets

-4.84%

Earnings Yield

-14.77%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

CA$174.68MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

136.47M

Volume

1.05K

Avg. Volume

204.57K

Financials (TTM)

Gross Profit

-CA$8.41M

Operating Income

-CA$105.88M

EBITDA

-CA$40.84M

Operating Cash Flow

-CA$9.01M

Capital Expenditure

-CA$11.19M

Free Cash Flow

-CA$20.20M

Cash & ST Invst.

CA$54.75M

Total Debt

CA$8.20M

Organigram Global Performance Analysis

Organigram Global annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-08-31CAD 145,809,00084.2%
20232023-09-30CAD 149,205,7282.3%
20242024-09-30CAD 159,841,0007.1%
20252025-09-30CAD 259,183,00062.2%
Organigram Global sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-06-307.9%
Q42025-09-3013.1%
Q12025-12-31-20.6%
Q22026-03-31-5.9%
Organigram Global annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-08-31CAD -0.19-90.9%
20232023-09-30CAD -2.821425.9%
20242024-09-30CAD -0.48-83.1%
20252025-09-30CAD -0.19-59.3%
Organigram Global sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-06-30-114.7%
Q42025-09-30-495.7%
Q12025-12-31153.6%
Q22026-03-31-104.7%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

CA$59.79M

-8.9%

Gross Profit

-CA$9.01M

-148.9%

Gross Margin

-15.06%

N/A

Market Cap

CA$174.68MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

CA$155.96K

N/A

Employees

1,120

N/A

Net Income

-CA$921.00K

-102.2%

EBITDA

-CA$28.01M

-920.7%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

CA$54.75M

+289.6%

Total Debt

CA$8.20M

-14.0%

Accounts Receivable

CA$53.39M

+6.8%

Inventory

CA$135.16M

+17.5%

Long Term Debt

CA$7.24M

-12.0%

Short Term Debt

CA$957.00K

-26.7%

Return on Assets

-4.84%

N/A

Return on Invested Capital

-24.48%

N/A

Free Cash Flow

-CA$6.53M

+71.8%

Operating Cash Flow

-CA$6.30M

+62.0%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
HLS.TOHLS Therapeutics Inc.
CA$4.15-1.43%
ACB.TOAurora Cannabis Inc.
CA$3.73-0.80%
WEED.TOCanopy Growth Corporation
CA$1.28-1.54%
TSND.TOTerrAscend Corp.
CA$0.76+1.33%

Trending Stocks

Symbol / CompanyPricePrice Chg
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$8.62-0.21%
AALAmerican Airlines Group
$13.62-0.08%
TQQQProShares Trust - ProShares UltraPro Qqq
$67.81-0.04%
SQQQProShares Trust - ProShares UltraPro Short Qqq
$42.38+0.04%

Questions About OGI

What is the current price of Organigram Global?

Organigram Global is trading at CA$1.29 per share.

What is the 52-week range for Organigram Global?

Over the past 52 weeks, Organigram Global has traded between CA$1.20 and CA$3.09.

How much debt does Organigram Global have?

As of the most recent reporting period, Organigram Global reported total debt of CA$8.20M.

How much cash does Organigram Global have on hand?

Organigram Global reported CA$53.94M in cash and cash equivalents in its most recent financial results.

What is Organigram Global’s dividend yield?

Organigram Global does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services